Podcasts about diagnostics

In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including:The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection)Cough as the most significant symptom and burdenImaging bronchiectasis with classic and inflammatory findingsDifferentiating the causes of NCFBE to inform patient carePresentersBrett M. Elicker, MDProfessor of Clinical RadiologyChief, Cardiothoracic Imaging DivisionDepartment of Radiology & Biomedical ImagingUniversity of California, San FranciscoSan Francisco, CaliforniaDavid E. Griffith, MD, ATSF, FACCP, FRSMProfessor of MedicineDivision of Mycobacterial and Respiratory DiseasesDepartment of MedicineNational Jewish HealthDenver, ColoradoProgram page: https://bit.ly/4mZbYsm

In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including:The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection)Cough as the most significant symptom and burdenImaging bronchiectasis with classic and inflammatory findingsDifferentiating the causes of NCFBE to inform patient carePresentersBrett M. Elicker, MDProfessor of Clinical RadiologyChief, Cardiothoracic Imaging DivisionDepartment of Radiology & Biomedical ImagingUniversity of California, San FranciscoSan Francisco, CaliforniaDavid E. Griffith, MD, ATSF, FACCP, FRSMProfessor of MedicineDivision of Mycobacterial and Respiratory DiseasesDepartment of MedicineNational Jewish HealthDenver, ColoradoProgram page: https://bit.ly/4mZbYsm

“We started Cleerly with the intent to make a comprehensive care pathway for evaluation, education, treatment and tracking for heart disease,” said Dr. Jim Min, the company’s founder and CEO. In this Vanguards of Health Care episode, Min sits down with BI analyst Matt Henriksson to discuss Cleerly and its comprehensive management platform that uses AI algorithms to boost the accuracy of interpreting CT scans, avoid false positives and make the diagnosis stage of treating the disease more efficient for doctors and hospitals. They also cover the need to drive the iterative process of clinical studies, including the TRANSFORM randomized trial for screening asymptomatic individuals with the aim of preventing sudden cardiac death.See omnystudio.com/listener for privacy information.

On today's episode, Dr. Mark Costes welcomes Jordan Reiss, Senior Director of Clinical Strategic Development at DEXIS, live from the Thrive Live exhibition hall in Las Vegas. With a background that spans management consulting at KPMG to dental tech innovation, Jordan shares how he found his passion in dentistry and 3D imaging. The conversation explores how CBCT is transforming not just implantology, but also endodontics, orthodontics, and aligner therapy.   Jordan highlights the evolving need for clinician education in CBCT interpretation, the rise of AI-enhanced imaging workflows, and the comprehensive ecosystem DEXIS is building to support diagnostics and patient care. He also shares personal stories about parenting, mission work, and the unexpected roads that lead to a meaningful career. Be sure to check out the full episode from the Dentalpreneur Podcast! EPISODE RESOURCES https://dexis.com https://www.truedentalsuccess.com Dental Success Network Subscribe to The Dentalpreneur Podcast

  How familiar are you with partnerships and collaborations between the laboratory and the diagnostics industry? In this episode Luis is joined by Dr. Andrea Prinzi and Dr. Kristen Smith to explore how partnerships between clinical labs, public health institutions, and the diagnostics industry drive innovation in in-vitro diagnostics (IVDs).  What is the IVD pipeline? From discovery to product launch and beyond, these collaborations improve patient care, accelerate access to new technologies, and enhance public health outcomes. Why breaking silos and fostering inclusive partnerships is essential for the future of diagnostics? Tune in to find out.  Link to article: https://doi.org/10.1016/j.clinmicnews.2025.04.001 Questions? Feedback? Send those to letstalkmicro@outlook.com Want to support the podcast? Here's how: Venmo: https://venmo.com/u/letstalkmicro Buy me a Ko-fi: https://ko-fi.com/letstalkmicro  

In this second episode of our lung cancer miniseries, Jonathan Sackier is joined by David Baldwin, a leading expert in screening, epidemiology, and policy. Baldwin reflects on national screening programmes, groundbreaking trials, and how AI, big data, and evidence-based guidelines are reshaping lung cancer care. Timestamps: 00:00 – Introduction 03:17 – Key takeaways from the UKLS trial 11:10 – Boosting participation in screening studies 17:04 – The Targeted Lung Health Check programme 23:30 – Understanding large datasets in lung cancer epidemiology 32:44 – AI and big data in lung cancer imaging 41:43 – Shaping national guidelines 47:47 – Are we doing enough to prevent lung cancer? 53:06 – Baldwin's three wishes for healthcare

This week, Ferg chats with Greg Mirams, founder of Techion/FECPAK. What started as a tool to do worm egg counts on-farm has evolved into a digital platform that reads samples using AI, returns results in minutes, and is helping farmers tackle drench resistance head-on.They cover the early days of FECPAK, how AI is speeding up diagnosis, what species ID could unlock for breeders, and why post-treatment testing matters more than ever.• Why drench resistance is no longer a “maybe” and what farmers can actually do about it.• How AI now reads worm egg counts in minutes.• The upcoming ability to identify worm species, making treatments far more targeted.• How egg count data is being used to track contamination, inform grazing plans, and map resistance across regions.https://fecpak.com/nzHead Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, and Heiniger Australia and New Zealand. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out Heiniger's product range HERECheck out the MSD range HERECheck out Allflex products HERE

In this special Pride Month episode of Tech It to the Limit, co-hosts Sarah Harper and Elliott Wilson dive into LGBTQ+ health equity, inclusive tech, and leading authentically in healthcare. They're joined by Jason Bellett, Co-Founder and Chief Business Officer at Eko Health, whose intelligent stethoscope is transforming how providers detect heart disease. Jason opens up about his journey as an openly gay founder, the intersection of innovation and equity, and the urgent need for inclusive leadership.Key TakeawaysLGBTQ+ healthcare has come a long way—but the fight for equity and access continues.Eko Health's AI-powered stethoscope enables early heart disease detection through FDA-cleared algorithms and inclusive design.Algorithmic equity matters: representative datasets and diverse health partners are key to reducing bias.Authentic leadership in healthcare requires visibility and courage, especially in today's climate.In the face of policy rollbacks, private sector leaders must step up to build inclusive tech and equitable systems.In this episode:[00:00:00] Pride Month kickoff + queer health visibility[00:01:25] “Holz Check” LGBTQ+ healthcare rights timeline[00:08:27] 10+ health tech companies advancing queer care[00:12:28] Interview with Jason Bellett[00:15:30] What is an intelligent stethoscope?[00:20:15] Equity in AI + reducing algorithmic bias[00:25:35] Eko's role in smart hospitals and virtual care[00:27:46] What Jason wishes he knew 10 years ago[00:31:05] Leading authentically as a gay founder[00:34:14] Advice for LGBTQ+ health tech professionals[00:38:45] Call to action for DEI in healthcare[00:42:22] Spicy Nuggets: Buzzwords, pride, and cootiesResources and LinksJason BellettLinkedIn Eko HealthPride Month SpotlightsFolks Health Plume HealthQueerDocOutCare HealthHoward Brown HealthMazzoni CenterFenway Health Euphoria AppsMyLabBoxFor ThemEquality MD

In this episode of Behind the Breath, Marjorie Cullinan, MSHA, RRT, RRT-NPS, RPFT, Operations Manager of Pulmonary Function Testing at Yale New Haven Hospital, sits down with AARC Vice President of Membership and Customer Care, Monique Kimmel to discuss the importance of AARC resources and networking in the Diagnostics Specialty Section, her journey in adult and pediatric respiratory critical care, and how her mentors help shape her career.Additional Resources AARC Diagnostics Specialty SectionBehind the Breath Video with Marjorie Cullinan and Monique KimmelSend us a textSupport the show

In the third and final episode of our miniseries on infectious disease diagnostics, Jonathan sits down with global diagnostics leader Rosanna Peeling, Professor and Chair of Diagnostics Research at the London School of Hygiene and Tropical Medicine. Together, they explore the life-saving role of diagnostics in global health, from battling STDs to confronting COVID-19, and examine how equitable access, social innovation, and regulatory reform can transform disease control and pandemic preparedness.   Timestamps: 00:00 – Introduction 06:09 – Rosanna's interest in microbiology 08:12 – The IDC's work 10:52 – Funding for diagnostics 13:30 – Diagnostic testing in low-resource settings 18:21 – Chlamydia research 24:19 – Regulatory approval challenges 29:35 – Social innovation 34:08 – Clinician adaptation 37:10 – Current diagnostic innovations 40:30 – Rosana's three wishes for healthcare

In healthcare, some of the most meaningful innovations happen when the right people are brought together in the right place. True progress depends on systems and infrastructure designed to connect ideas, people, and expertise across sectors. Citylabs 4.0, now open in the heart of Manchester's Knowledge Quarter on the Oxford Road Corridor, was built with exactly that goal in mind. Bringing the NHS, academia, and life sciences organisations into close, purposeful proximity, providing a structural foundation for collaboration at scale. In this special live recording of the pharmaphorum podcast, developed in association with Bruntwood SciTech, Bruntwood SciTech's CSO Dr Kath Mackay, Manchester University NHS Foundation Trust T's Dr Katherine Boylan, and Dr Gillian Dalgliesh from QIAGEN join Deep Dive editor Eloise McLennan onstage at the opening of Citylabs 4.0 to discuss innovation in life sciences and the role of Greater Manchester in accelerating research, industry collaboration, and real-world evidence generation. Join us as we examine how this deliberate integration of healthcare stakeholders in Manchester is establishing new standards for collaboration and advancing patient outcomes through structured knowledge exchange. About the interviewees Dr Kath Mackay Kath Mackay is Chief Scientific Officer of Bruntwood SciTech - a JV between leading property developer Bruntwood, Legal & General, and Greater Manchester Pension Fund - the UK's leading creator and developer of innovation districts driving growth of the UK science and technology sector.  She has a keen interest in growing businesses and infrastructure within the sector, ensuring the UK is the best place to establish and scale a science and tech organisation.   Dr Mackay joined Bruntwood SciTech from the executive board of Innovate UK where she led the team responsible for growing businesses working in the biomedical, health, agriculture, and food sectors, creating and delivering a £800m portfolio of infrastructure, Catapults, grant and loan investments. She is also non-executive director of the Northern Health Science Alliance, the North of England's health partnership, and an elected fellow of the Royal Society of Biology. Dr Katherine Boylan Katherine is Director of Innovation at Manchester University NHS Foundation Trust (MFT), a position she has held since April 2020. This role involves overseeing innovation activities within MFT, as part of the wider Research and Innovation function. Innovation at MFT supports the whole pipeline from ideation, through to evidence generation, and ultimate implementation. She has been a member of the NICE Medical Technologies Advisory Committee since September 2020. Prior to this position, Dr Boylan worked in the University of Manchester for a number of years, most recently as Operations Director for the MRC funded Molecular Pathology Node, and the Trust-funded Diagnostics and Technology Accelerator. Dr Gillian L Dalgliesh, PhD Global Technical lead, Precision Diagnostics Gillian Dalgliesh has worked for QIAGEN for nine years and is based at their Manchester site, which is the global centre of excellence for molecular diagnostic development. QIAGEN partner with many drug companies to develop companion diagnostic (CDx) tests that enable clinical trials and subsequently launches of novel precision medicines. In recent years they have seen a real move beyond oncology into other disease areas such as immune, neurological and metabolic disorders. Dr Dalgliesh's role as global technical lead allows her to leverage her oncology precision medicine experience across the portfolio to bring precision diagnostic products to more patients. She has built her experience in precision medicine/oncology through not only her QIAGEN role but also through seven years working in precision medicine in AstraZeneca and prior to that working as part of the cancer genome project at the Sanger institute. Dr Dalgliesh is also an honorary senior lecturer at University of Manchester where she coordinates and delivers lectures for a QIAGEN sponsored BSc final year elective module ‘The Role of Diagnostics in Medicine'. This is part of a wider outreach role with the University and our NHS hospital. Through these roles she is keen to impact the local UK science community. About Bruntwood SciTech Bruntwood SciTech is the UK's largest dedicated property platform serving the growth of the nation's knowledge economy to become a global science and technology superpower. It is also the leading developer of city-wide innovation ecosystems and specialist environments, helping companies - particularly those in the science and technology sectors - to form, scale and grow A joint venture between Bruntwood, Legal & General and the Greater Manchester Pension Fund (GMPF), Bruntwood SciTech provides high quality office and laboratory space and tailored business support, offering unrivalled access to finance, talent and markets, an extensive clinical, academic and public partner network and a sector-specialist community of more than 1100 companies. Bruntwood SciTech is experienced in creating and developing strategic partnerships with UK regional cities, universities and NHS Trusts to drive economic growth. Its unique structure and funding vehicle more easily deploys long-term patient capital in innovation infrastructure, ensuring local economic benefit and growth. Valued at £1.5bn, Bruntwood SciTech has a portfolio of 5.2m sq ft across 11 campus locations and 31 city centre innovation hubs in Manchester, Cheshire, Birmingham, Leeds, Liverpool, Cambridge and London. It has plans to create a £5bn portfolio by 2033 and has a 2.3m sq ft secured development pipeline. Its campus locations include Alderley Park in Cheshire; West Village in Leeds; Innovation Birmingham; Birmingham Health Innovation Campus in partnership with the University of Birmingham; Melbourn Science Park in Cambridgeshire; Liverpool Science Park as a shareholder in Sciontec Liverpool; White City Deep Tech Campus in partnership with Imperial College London; and a cluster in the heart of Manchester's Oxford Road Corridor knowledge quarter - Manchester Science Park, Citylabs in partnership with Manchester University NHS Foundation Trust (MFT), Circle Square - a joint venture with Vita Group; and the £1.7bn JV partnership with The University of Manchester - Sister, formerly known as IDManchester. Its city centre innovation hubs include Bloc, Bond, 111 Piccadilly, Pall Mall and Manchester One in Manchester; Platform in Leeds; Cornerblock and Centre City in Birmingham; and The Plaza in Liverpool. Website / Twitter / LinkedIn / Instagram

On this episode of Longevity by Design, Dr. Gil Blander sits down with Dr. Evelyne Bischof, President of the Healthy Longevity Medicine Society.  Evelyne discusses her background in internal medicine and oncology and how her work puzzling together patient diagnoses led her to the field of longevity medicine. She highlights the importance of optimizing health span, not just lifespan, and how healthy longevity medicine benefits not only individuals, but population health and the world economy as well.Gil and Evelyne explore the difference between longevity medicine and traditional healthcare. Evelyne explains that longevity medicine uses a broader range of diagnostics, including advanced biomarkers, imaging, and cognitive tests. This approach aims to build a personalized health trajectory for each patient. They also discuss the role of AI in healthcare, with Evelyne expressing hope for faster, AI-driven diagnostics and drug discovery in the future.Finally, they touch upon the Healthy Longevity Medicine Society, its mission to establish longevity medicine as a recognized medical discipline, and the exciting developments in the field, such as the SHARP study at the Sheba Longevity Center. Evelyne emphasizes the importance of being data-driven and encourages listeners to collect and track their own health data. She believes this empowers individuals to make informed decisions about their health and longevity.Guest-at-a-Glance

In this episode of the Tacos & Tech Podcast, host Neal Bloom sits down with CEO of Pictor, a diagnostics company transforming healthcare through proteomics-the science of understanding what the body's proteins are doing right now. They explore how this next-generation technology is shifting the medical world from slow, reactive testing to real-time, accessible diagnostics for both humans and animals. From Jamie's early days at Quest Diagnostics to Pictor's move from New Zealand to San Diego, this episode is a front-row seat to how health innovation really happens. Whether you're building a biotech startup or just curious about how your body actually works, this conversation reveals what's next for diagnostics-and why it matters now more than ever.   Key Topics Covered What proteomics is-and why it matters more than ever The shift from DNA-based tests to real-time protein diagnostics Pictor's expansion to Carlsbad and why San Diego is a healthtech hotspot How regulatory clarity is speeding up innovation Lessons in leadership and conviction from Jamie's founder journey Making diagnostics faster, cheaper, and more personal   Links & Resources Pictor Diagnostics   Connect with Jamie LinkedIn Connect with Neal Bloom LinkedIn Twitter

Savannah Applegate, Ph.D. is a Senior Consultant at Elanco Poultry Food Safety. Dr. Applegate received her B.S. degree in Meat Science from Ohio State University and her M.S. degree and Ph.D. in Applied Food Microbiology from Texas Tech University. Her areas of expertise are meat and poultry food safety, and she specializes in diagnostics and pathogen mitigation.  In this episode of Food Safety Matters, we speak with Dr. Applegate [1:10] about: The importance of diagnostics for ensuring food safety and implementing effective disease management protocols in the poultry industry Common misconceptions among industry about diagnostics and how to effectively implement diagnostic tests on-farm Key first steps to integrating effective diagnostic testing protocols alongside biosecurity programs The difference between serotyping data versus quantitative data, and the importance of both to determining the effectiveness of Salmonella vaccines for poultry Support and solutions offered by Elanco for collecting and interpreting serotyping and quantification data to improve poultry food safety outcomes. Sponsor Elanco We Want to Hear from You!Please send us your questions and suggestions to podcast@food-safety.com

Welcome to Buffalo HealthCast, the official podcast of the University at Buffalo's School of Public Health and Health Professions

Dev Mittar, Ph.D., Scientific Director of the ASM Health Scientific Unit discusses the use of metagenomic next generation sequencing to develop agnostic diagnostic technology, giving scientists and clinicians alike, a tool to diagnose any infectious disease with one single test. He also discusses how the ASM Health Unit is empowering scientists and leveraging microbial science innovations to address critical global health challenges and improve lives worldwide. Ashley's Biggest Takeaways The Division of Research, Innovation and Ventures is a small entrepreneurial arm of BARDA that takes on early-stage projects with high potential of turning into medical countermeasures. Prior to his role as Scientific Director for ASM Health, Mittar worked as a health scientist and program officer at DRIVe, where he focused on advancing high-impact science. He is particularly passionate about his work to develop agnostic diagnostics—a single test that uses metagenomic next generation sequencing to identify any pathogen from 1 clinical sample. Mittar discusses applications for this technology in surveillance (pandemic preparedness), variant detection, AMR and clinical settings (diagnosing complicated infections where etiology is not clearly defined). He also shares how a recent bout with illness emphasized the value and potential of this technology to save money, time, pain and suffering of the patient. Agnostic diagnostics can also help prevent the overuse/misuse of antibiotics, which are key factors in the spread of antimicrobial resistance. Furthermore, when this technology is coupled with the use of metatranscriptomics, it can provide information about the patient's immune profile that can be helpful in developing personalized treatment strategies, as opposed to a one-size-fits-all approach. ASM is organizing around 3 scientific units, ASM Health, ASM Mechanism Discovery and ASM Applied and Environmental Microbiology. These units will empower researchers and scientists to use science make a difference in the world and provide a forum for them to come together to shape the future of the field. Links for This Episode Learn More About ASM's Scientific Units. Join the Conversation on ASM Connect, our online community platform. Browse Volunteer Opportunities. Become an ASM Member. Register for ASM Microbe 2025.

Lisa Giganti Chief Executive Officer at Lumina Imaging and Diagnostics. Lisa Giganti is a dynamic leader with extensive experience in strategic planning, innovation, and financial management. As the Chief Executive Officer of Lumina Imaging and Diagnostics, Lisa is at the forefront of transforming and disrupting the medical imaging landscape. Her work focuses on developing strategic partnerships and shared risk/reward ventures to enhance access to quality medical imaging while upholding the highest standards of care and exceptional patient experience.   Prior to Lumina, Lisa was a Managing Principal in Strategy and Innovations at The MetroHealth System in Cleveland, Ohio where she was responsible for identifying, prioritizing, developing, and executing strategic initiatives in alignment with the organization's mission. Her approach included data-driven analyses and process assessments to improve and expand medical services such as Bariatric Surgery, Radiology, and Breast Health. Lisa's career began in finance spanning a variety of disciplines in the rental car and hospitality industries for both large corporations and start-ups. She then pivoted to banking for 10 years in progressively advanced roles as a Business Performance Improvement Consultant, Retail Banking Controller and Corporate Banking CFO at National City Corporation / PNC Bank.   Ultimately, Lisa found her calling in healthcare, aligning her passion for health and wellness with her strong business acumen.  She served as a Senior Project Manager in Strategic Financial Planning at Cleveland Clinic, honing her skills in financial strategy and large-scale project management.   Lisa earned her Bachelor of Science in Business Administration with a focus on Finance and Economics from John Carroll University and later obtained her Master of Business Administration from Cleveland State University, concentrating in Finance and Management.   Lisa's diverse background and strategic mindset have established her as an effective leader able to drive growth and innovation in the healthcare, financial services, and hospitality sectors.

In today's VETgirl online veterinary continuing education podcast, Dr. Michelle Evason, BSc, DVM, DACVIM, MRCVS, Global Director of Veterinary Clinical Education at Antech, and Dr. Jimmy Barr, DACVECC, Chief Medical Officer at Antech, part of Mars Science & Diagnostics, discuss vector borne disease including spectrum of care. Screening dogs for vector-borne disease pathogens, like Lyme and Heartworm, occurs annually in veterinary clinics across the US and Canada. Listen in for updates on innovations and practical pearls on pet-owner communication & shared-decision-making across the diagnostic spectrum of care.Sponsored By: Antech, MARS

Thanks to our Partners, NAPA TRACS, and Today's Class Recorded at the TST Big Event, industry trainers Eric Ziegler and Pete Meier dive into the growing challenges technicians and shop owners face in staying current with technology and why continuous education is no longer optional. The conversation highlights key issues including the liability risks of inadequate training, the double-edged sword of social media as an information source, and the power of peer-to-peer knowledge sharing. Eric and Pete also stress the importance of actively applying what's learned, not just passively consuming information, and how networking with other professionals can accelerate growth. Eric Ziegler, EZ Tech Mentors.  Eric's previous episodes HERE. Pete Meier, Training Manager, Dorman Products. Pete's other episodes HERE Show Notes: Watch Full Video Episode TST Big Event 2025: https://www.tstseminars.org/ Introduction to the Episode (00:00:00) Overview of Training Importance (00:01:03) Cultural Shift in Training (00:03:04) Incentivizing Training (00:04:08) Training Formats and Challenges (00:05:00) Technician Growth and Retention (00:06:55) Advocating for Continuing Education (00:07:40) Financial Commitment to Training (00:08:20) Cultural Commitment to Education (00:09:24) Awareness of Training Resources (00:10:09) Networking at Training Events (00:11:19) Building a Positive Training Culture (00:12:52) Value of Training Experiences (00:14:04) Networking Importance (00:14:38) Training Takeaways (00:14:59) Building a Training Culture (00:18:56) Mentorship in the Industry (00:19:05) Service Information Awareness (00:21:50) Consequences of Ignoring Updates (00:22:39) Importance of Accurate Training (00:26:02) Battery Maintenance and Diagnostics (00:28:17) Technician Homework (00:30:53) Social Media's Role in the Industry (00:31:22) Generational Changes in Automotive Skills (00:33:30) Quality vs. Price in Automotive Services (00:36:40) Vetting Information Sources (00:38:24) Making Training Practical (00:41:19) The Forgetting Curve (00:42:19) Taking Action on Learning (00:43:05) Business Perspective on Training (00:43:43) Changing Technician Compensation (00:44:53) Thanks to our Partner, NAPA TRACS NAPA TRACS will move your shop into the SMS fast lane with onsite training and six days a week of support and local representation. Find NAPA TRACS...

This week, Lauren welcomes UI College of Public Health alumnus and recipient of the college's 2024 Outstanding Alumni Award, Dr. Vijay Golla. They discuss his journey into public health that began with his medical training in India, where he became interested in preventive medicine and social medicine. This led him to pursue a Ph.D. in industrial hygiene at the University of Iowa, where he focused his dissertation on assessing pesticide levels and related doses among farm families in Iowa. After graduating, Dr. Golla returned to Western Kentucky University, where he obtained a training grant to support undergraduate and graduate students in environmental health sciences. In his current role as Vice Provost for Research and Health Sciences at Texas A&M, Dr. Golla has been able to significantly increase research funding and expand the university's health science initiatives, which he sees as a critical part of public health's future focus on disease prevention. Dr. Golla emphasizes the importance of field experience, networking, and staying research-active for current public health students and young professionals. He is excited about public health's growing influence and its potential to play a pivotal role in providing personalized preventive healthcare recommendations, much like a vehicle's diagnostic system. A transcript of this episode is available at https://www.public-health.uiowa.edu/news-items/plugged-in-to-public-health-a-conversation-with-dr-vijay-golla/ Have a question for our podcast crew or an idea for an episode? You can email them at CPH-GradAmbassador@uiowa.edu You can also support Plugged in to Public Health by sharing this episode and others with your friends, colleagues, and social networks. #publichealth

In this episode of From First Period to Last Period, Shea shares her harrowing experience with ⁠hyperemesis gravidarum⁠ — a severe and often misunderstood form of morning sickness that made her pregnancy nearly unbearable.⁠Dr. Jenna Kahn⁠ also shares some big personal news: she's in the process of freezing her embryos. She takes us behind the scenes of the emotional and medical steps involved, and what this decision means for her future fertility.Noticed ⁠mid-cycle spotting⁠ and unsure what it means? We break down the possible causes — from harmless hormonal changes to signs you shouldn't ignore — and when it's time to call your doctor.And in a glimpse at the future of reproductive health, we explore how ⁠menstrual blood⁠ could become a powerful diagnostic tool. Meet the companies leading this innovation and learn how their work could revolutionize early detection and care.Hit play now on ⁠⁠Spotify⁠⁠, ⁠⁠Apple Podcasts⁠⁠, ⁠⁠YouTube⁠⁠, or wherever you listen.

Episode: 3014 Measuring Almost Nothing.  Today, we measure almost nothing.

Dr. Gil Blander welcomes Dr. Daniel Durand, Chief Medical Officer at Prenuvo, to Longevity by Design for a deep dive into the future of preventative healthcare. Dr. Durand shares how full-body MRI is redefining early detection by making advanced imaging accessible, non-invasive, and radiation-free. He explains why MRI, as a soft tissue imaging modality, offers unmatched insight into early-stage cancers and chronic conditions.The conversation unpacks misconceptions around overdiagnosis and false positives, challenging the idea that “not knowing” is safer. Dr. Durand outlines how AI-enhanced imaging, paired with structured follow-up care, reduces unnecessary biopsies and improves diagnostic accuracy. He also discusses the emotional and systemic costs and benefits of proactive screening.Looking ahead, Dr. Durand envisions a healthcare model built on data, personalization, and patient empowerment. He argues that gathering better information, earlier, will shift the focus from treatment to prevention and help more people maintain peak health for longer. Guest-at-a-Glance

Like the show? Show your support by using our sponsors.Promotive can help you find your dream job, or help you hire. Touch HERE for more.Need to update your shop systems and software? Try Tekmetric HEREIn this episode, Jeff Compton and Lucas Underwood get real about the realities of shop ownership and the repair industry. Lucas harps on why you need to build better systems and processes, mainly to avoid burnout. They both get heated about the technician pay structure, industry culture, and the crucial need for personal fulfillment and meaning beyond monetary success.00:00 Intense Storms, Tornado Near Miss06:15 "True Champions Plan for Success"10:49 Complex Challenges in Industry Dynamics20:06 Self-Reflection and Employee Turnover25:07 Owner's Struggles with Management30:23 "Chaotic Kitchen Reflections"31:12 Automotive Industry Training Challenges41:23 Welfare System Critique: Misallocation Concerns45:03 Track and Tax Unbilled Services47:12 Business Finance Transparency Needed56:07 Rethinking Success Beyond Money59:04 Career Pathing Concerns Discussed01:03:14 Fishing: A Passionate Escape01:12:29 Navigating Professional Boundaries01:14:36 "Embracing Emotional Connections"01:20:59 Helping Each Other: A Pipe Dream?01:27:13 Eco Diesel Truck Dilemma01:32:17 Online Complaints Over Car Repairs01:38:54 Unnecessary Changes Disrupt Growing Shop01:40:52 Emotion-Free Decision Making01:46:20 "Challenging Stagnant Business Practices"01:52:54 Building Character Through Purposeful Work Follow/Subscribe to the show on social media! TikTok - https://www.tiktok.com/@jeffcompton7YouTube - https://www.youtube.com/@TheJadedMechanicFacebook - https://www.facebook.com/profile.php?id=100091347564232

Session 4 ‘Novel Approaches to Pathogen Detection and Sepsis Diagnostics' from the 5th World Sepsis Congress. Featuring Evdoxia Kyriazopoulou, Thorsten Brenner, Larissa May, Irit Gat-Viks, Olawale Ajose, and Konrad Reinhart as your moderator.

Key Takeaways: Dr. Louis Teulières, a multi-national doctor with an MD and PhD, has been actively involved with ILADS since 2016 due to his research on bacteriophages at the University of Leicester. Frustrated with the limitations of antibiotic treatments for Borrelia, the bacteria that causes Lyme disease, Dr. Teulières explored bacteriophages as a novel diagnostic and therapeutic approach. Due to regulatory challenges in administering phage therapy, Dr. Teulières and his team developed a phage-based test that can directly detect the presence of Borrelia bacteria. This test, marketed by Red Labs in Europe for the past four years, has been used on thousands of patients and can differentiate between early, late-stage, and post-treatment Lyme disease. Dr. Teulières is now working to expand the test's reach in the U.S., seeking partnerships with American clinicians and researchers to validate the test and pursue FDA clearance. The discussion underscores the need for innovative diagnostic tools to improve Lyme disease detection and accelerate healing journeys for patients. About Dr. Louis Teulières: Medical degree from University of Nice, France. Specializations in immunology, hematology, immunopathology, bacteriology, and epidemiology at the Pasteur Institute in Paris and CDC in Atlanta. Former researcher at the Pasteur Institute, contributing to studies on immune and infectious diseases such as HIV. Active member of the immunology team that received the Nobel Prize in 2008 for discovering the HIV virus in 1983. Founder of CMIL clinics in Lisbon and Paris, specializing in immune and infectious diseases, Lyme disease, and neurodegenerative conditions. Co-founder of PHELIX, a charity dedicated to phage-based research and diagnostics in Lyme disease. Collaborates with University of Leicester, St Thomas Hospital in London, and other world-class healthcare professionals. Resources & Links: Follow the latest ILADS updates: ILADS.org Learn more about Dr. Louis Teulières and his research: Red Labs Stay connected with Tick Boot Camp: Website | Instagram | Facebook | YouTube | TikTok | Twitter (X)

00:00:00 Surf's Up, Season 6, Episode 6.On April 23, 2024, our colleague and co-founder, Stephen Harrison, passed away suddenly. This week, Surfing the MASH Tsunami remembers Stephen with two of his closest associates and continues our annual MASH Drug Development roundtable held in his honor. 00:00:04:24 - A Deep Dive into Drug Development, Part 2The second portion of the Drug Development roundtable primarily focuses on three key issues. The first, uptake of resmetirom, starts with Naim Alkhouri discussing his experience in the Arizona Liver Health Clinics with over 650 patients in the year since resmetirom was approved and shifts to the various European panelists (Jörn Schattenberg, Louise Campbell and Sven Francque) estimating when it might be approved in their countries and how widely it might be reimbursed.  The second topic, incretin agonists, focuses on exciting prospects for other incretin agonists in development, as well as some semaglutide combination therapies. The third, NIT clinical trials, covers prospects that non-biopsy clinical trials might be approved sometime in the near future.00:16:20 - Remembering Stephen Harrison I: An Interview with Summit Clinical Research CEO Gail HinksonSummit CEO Gail Hinkson joins Roger Green for the first time on SurfingMASH to discuss her business partner. Gail discusses how the two originally formed Pinnacle Clinical Research and how Pinnacle led to Summit. She proceeds to discuss the current size and reach of both Pinnacle and Summit. Focusing on Summit, Gail describes the company as an Integrated Research Organization (IRO), highlighting its distinct role within the MASH firmament. In the final section of the interview, Gail discusses how Stephen's personality, goals, and vision continue to live on at Summit today.00:34:31 - Remembering Stephen Harrison II: An Interview with Naim Alkhouri Announcing That He Is Joining SummitNewly announced Summit Chief Academic Officer Naim Alkhouri joins this episode for a second time, but in a very different role. Naim discusses his personal history with Stephen and what he loved and respected about his "dear friend." He then makes a major announcement: he is joining Summit as Chief Academic Officer. He shares the many elements of this role, particularly his excitement that Summit can become the entity that educates a wide range of healthcare and commercial professionals on what MASH is and how it is treated. The scope of this vision, combined with what Gail discussed, portrays a level of energy, ambition and vision worthy of Stephen Harrison.00:55:55 - ConclusionAs part of this memorial week, Roger Green forgoes the usual business report, which will return next week.

In the second episode of our miniseries on infectious disease diagnostics, Jonathan is joined by molecular epidemiologist Rodney Rohde, Regents' Professor at Texas State University, USA. Together, they explore diagnostic innovations in the fight against antimicrobial resistance, gaps in zoonotic disease detection, and the persistent challenge of vaccine hesitancy. Timestamps: 00:00 – Introduction 01:45 – Breakthroughs in molecular diagnostics 08:30 – Diagnostic tools to combat superbugs 14:18 – Can bacteriophages replace antibiotics? 19:04 – Controlling rabies and hantavirus 28:33 – Diagnostic successes and failures from COVID-19 35:22 – How do we address vaccine hesitancy? 44:10 – Preparing for the next pandemic 47:03 – Rohde's three wishes for healthcare

Gary Falcetano, Scientific Affairs Manager for Allergy at Thermo Fisher Scientific, is a leader in allergy and autoimmune diagnostics, providing specific IgE tests and the instruments to run them. Accurately diagnosing allergies can be challenging, but specific IgE testing can help confirm the underlying causes by looking at individual allergen components for precise diagnosis. This is the first step in determining the appropriate management approach to potentially interrupt the atopic march, where allergies can progress or even be life-threatening. Gary explains, "It runs the gamut of just about anything that could potentially be an allergy disease. So I think the majority of our testing is done in both environmental allergies and food allergies. What people think about when we, especially this time of year in the US, with spring about to become a big onslaught, are environmental allergies, including pollens, grass, trees, and weeds. Also, looking at some of the indoor triggers to environmental allergies like dust mites, pets, molds, and mice is pretty key when assessing for respiratory-type symptoms. On the food side, any of a number of foods can potentially cause a patient to produce specific IgE, which is the sensitization that allows us to become allergic." "We all think of respiratory allergies as straightforward, but there's an overlap of symptoms, especially from non-allergic causes, that can cause similar symptoms. So when thinking about respiratory allergies, we think about nasal congestion, post-nasal drip, and cough. Those symptoms can all be certainly caused by allergies, but they also can be caused by non-allergic triggers. That's one of the places where diagnostic allergy testing or specific IgE testing comes in to confirm whether we're dealing with an allergy. Then, if it's an allergy, what specifically is driving the symptoms? Once we rule out allergy, we can go down a whole other diagnostic pathway for all the various causes, like non-allergic rhinitis." #ThermoFisherScientific #Allergies #AllergyTesting #ClinicalDiagnostics #PatientCare #IgETesting thermofisher.com Download the transcript here

Gary Falcetano, Scientific Affairs Manager for Allergy at Thermo Fisher Scientific, is a leader in allergy and autoimmune diagnostics, providing specific IgE tests and the instruments to run them. Accurately diagnosing allergies can be challenging, but specific IgE testing can help confirm the underlying causes by looking at individual allergen components for precise diagnosis. This is the first step in determining the appropriate management approach to potentially interrupt the atopic march, where allergies can progress or even be life-threatening. Gary explains, "It runs the gamut of just about anything that could potentially be an allergy disease. So I think the majority of our testing is done in both environmental allergies and food allergies. What people think about when we, especially this time of year in the US, with spring about to become a big onslaught, are environmental allergies, including pollens, grass, trees, and weeds. Also, looking at some of the indoor triggers to environmental allergies like dust mites, pets, molds, and mice is pretty key when assessing for respiratory-type symptoms. On the food side, any of a number of foods can potentially cause a patient to produce specific IgE, which is the sensitization that allows us to become allergic." "We all think of respiratory allergies as straightforward, but there's an overlap of symptoms, especially from non-allergic causes, that can cause similar symptoms. So when thinking about respiratory allergies, we think about nasal congestion, post-nasal drip, and cough. Those symptoms can all be certainly caused by allergies, but they also can be caused by non-allergic triggers. That's one of the places where diagnostic allergy testing or specific IgE testing comes in to confirm whether we're dealing with an allergy. Then, if it's an allergy, what specifically is driving the symptoms? Once we rule out allergy, we can go down a whole other diagnostic pathway for all the various causes, like non-allergic rhinitis." #ThermoFisherScientific #Allergies #AllergyTesting #ClinicalDiagnostics #PatientCare #IgETesting thermofisher.com Listen to the podcast here

In this forward-looking episode, we dive into the evolving frontier of machine vision AI with Maria Greicer, VP of Partnerships at Keymakr. With over 18 years of global experience across the EU, U.S., and Israel, Maria blends a sharp entrepreneurial eye with deep knowledge of medical AI to shape how tomorrow's healthcare technologies are built today. From her early work in information technologies to leading high-impact growth initiatives at AI startups, Maria's career offers a rare look inside the world of healthcare tech innovation. Tune in as we unpack: How visual AI is accelerating diagnostic accuracy in radiology and ultrasound What makes AI in medicine so uniquely powerful in clinical settings Why remote diagnostics and real-time imaging analysis are game-changers The continuous learning loop that makes edge AI smarter every day Whether you're fascinated by smart healthcare, AI diagnostics, or the future of digital medicine, this conversation delivers. Follow Maria and the cutting-edge work happening at Keymakr now! Episode also available on Apple Podcasts: https://apple.co/38oMlMr

Callum and Alyssa are joined by Professor Malcolm Richardson to talk about all things fungal diagnostics.In this, part 1 of 2 on diagnostics we discuss the use of biomarkers such as beta-D-Glucan and galactomannan, as well as serology and molecular techniques.Notes for this episode can be found: here.Send us a textSupport the showQuestions, comments, suggestions to idiotspodcasting@gmail.com or on Bluesky @idiots-pod.bsky.socialPrep notes for completed episodes can be found here (Not all episodes have prep notes).If you are enjoying the podcast please leave a review on your preferred podcast app!Feel like giving back? Donations of caffeine gratefully received!https://www.buymeacoffee.com/idiotspod

Thanks to our Partners, NAPA TRACS, and Today's Class Tim Iezzi and Ira Waldman introduce their upcoming training class, "Labscope Essentials for the Ball Joint Guy," designed to build strong foundational skills in labscope diagnostics. Aimed at bridging the gap between hands-on mechanical work and advanced technology, the class offers practical, hands-on learning with ongoing support. Tim and Ira break down the curriculum, target audience, and the importance of real-world application to reinforce concepts. They also highlight the critical role of continuous education and why shop owner involvement is key to technician growth and long-term success. Tim Iezzi, Iezzi's Auto Service, Reading, PA Ira Waldman, Mallue's Automotive, Manasquan, NJ Watch Full Video Episode TST Big Event 2025: https://www.tstseminars.org/ "Labscope Essentials for the Ball Joint Guy" 9:00 AM - 5:00 PM on May 3-4, 2025. $495 per person (includes food and refreshments) Event Address: MACS Training Facility- 225 S Broad St, Lansdale, PA 19446 (back of the building). Contact us at: (484) 509-1494 or expertechtraining@gmail.com Guest Introductions (00:00:00) Training Class Announcement (00:02:04) Class Focus Discussion (00:03:16) Investment in Training (00:05:07) Hands-On Learning Approach (00:05:47) Understanding Good vs. Bad Data (00:08:40) Foundation of Skills (00:10:48) Target Audience for the Class (00:12:01) Electricity Basics Requirement (00:12:14) Limitless Potential of Labscopes (00:13:10) Remote Refresher Training (00:14:00) Career Pathing and Continuous Education (00:15:16) Testing Techniques for Diagnostics (00:16:32) Supporting Students Post-Class (00:17:12) Creating a Comfortable Learning Environment (00:20:10) Assessments in Training (00:22:18) Hands-On Labs as Assessment (00:24:30) Accountability in Learning (00:26:22) Engaging Shop Owners in Training (00:27:46) Incentives for Technicians (00:27:58) Upcoming Training Classes (00:28:31) Thanks to our Partner, NAPA TRACS NAPA TRACS will move your shop into the SMS fast lane with onsite training and six days a week of support and local representation. Find NAPA TRACS on the Web at http://napatracs.com/ Thanks to our Partner, Today's Class Optimize training with Today's Class: In just 5 minutes daily, boost knowledge retention and improve team performance. Find Today's Class on the web at https://www.todaysclass.com/ Connect with the Podcast: -The Aftermarket Radio Network: https://aftermarketradionetwork.com -Follow on Facebook:

In today's VETgirl online veterinary continuing education podcast, Dr. Holly Brown, ACVP discusses the importance of performing in-house diagnostics (IHD) - commonly known as point-of-care (POC) diagnostics - as part of routine patient care and patient differential diagnosis. In-house diagnostics include urinalysis, CBC, serum chemistries, parasitology and cytology evaluations...all key diagnostics that can be performed at the clinic with the resources you have! Tune in to learn more about the advancements and benefits of performing in-house diagnostics.Sponsored By: Antech, MARS

In this episode, Duane Mancini delves into the life science ecosystem in Kentucky with Christin Godale, Executive Director at LifeSciKY, and Nicholas Lyktey, Chief of Laboratory Operations at Gravity Diagnostics. Christin discusses the collaborative, bipartisan efforts driving innovation in the Commonwealth, including the launch of strategic initiatives and the benefits available to participating companies. Nicholas shares the remarkable growth story of Gravity Diagnostics, from a startup with 30 employees to a powerhouse of 330, highlighting the challenges and successes of rapid scaling. We also explore the partnership between Project Medtech and LifeSciKY and how it is shaping the future of the industry in Kentucky. Tune in to discover how strategic investments and collaborative partnerships are fueling a life science revolution in the heart of the Bluegrass State. Christin Godale, PhD  LinkedInNicholas Lyktey LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Duane Mancini LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Project Medtech LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Project Medtech Website ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Midwest Showcase Registration⁠

Host Uzma is an MD PhD and private practice neurosurgeon and brain injury researcher at the University of Minnesota.  She's also the founder of Oculogica, seeking to improve diagnostics for concussion. Together they discuss why concussion and TBI are so hard to diagnose and quantify the long term impacts as well as where science is at currently for both diagnosis and recovery protocols. Having also worked as a neurotrauma consultant to the National Football League from 2015 to 2018, they discuss contact sports and their risk and benefits. https://oculogica.com/

In this conversation, Dennis and Steven Blocker discuss the integration of AI in healthcare, particularly in emergency medicine. They explore the capabilities and limitations of various AI models, including large language models and natural language processing, and their applications in diagnostics, patient care, and education. The conversation also touches on the ethical considerations and accountability surrounding AI usage in medical settings, emphasizing the importance of understanding the technology's boundaries and ensuring patient safety. In this conversation, Steven Blocker and Dennis discuss the evolving role of AI in healthcare, emphasizing the importance of medical protocols, the responsibilities of healthcare providers, and the limitations of AI in clinical decision-making. They explore the potential for AI to assist in surgical procedures, the future of AI in medicine, and the need for AI to adapt to changing medical practices. The discussion highlights the necessity of human oversight in medical decisions and the importance of using AI as a tool to enhance, rather than replace, the clinician's expertise.TakeawaysAI has been around for a long time, but its recent popularity is notable.Understanding the bounds of AI is crucial for effective use.AI cannot be used offline, especially on mobile devices.Large language models provide answers with confidence but lack true understanding.Always fact-check AI outputs, as they may contain inaccuracies.AI can assist in triage processes but requires tailored software.Ethical considerations in AI usage are paramount in healthcare.AI can enhance education and training for medical professionals.The quality of AI-generated information must be critically evaluated.Accountability in AI usage is essential to prevent liability issues. It's crucial to adhere to medical protocols to avoid blame.Healthcare providers are ultimately responsible for patient decisions.AI should augment medical decision-making, not replace it.The effectiveness of AI in surgery depends on the data it is trained on.AI can assist medics but cannot replace their experience.AI needs sufficient data to make informed decisions.The future of AI in healthcare is promising but uncertain.AI must adapt to evolving medical practices and protocols.Using AI effectively requires understanding its limitations.AI can help summarize and analyze patient data efficiently.Chapters00:00 Introduction to AI in Medicine02:54 Understanding AI Models and Their Applications05:46 The Role of AI in Patient Care09:08 AI in Diagnostics and Decision Support12:05 AI in Education and Training15:08 Challenges and Limitations of AI in Medicine18:10 Ethics and Accountability in AI Usage20:50 Future of AI in Healthcare27:00 Navigating Medical Protocols and Responsibilities30:02 The Role of AI in Medical Decision-Making33:13 AI in Surgical Procedures: Potential and Limitations38:57 The Future of AI in Healthcare43:05 Adapting AI to Evolving Medical Practices48:08 Maximizing AI's Utility in Clinical SettingsThank you to Delta Development Team for in part, sponsoring this podcast.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠deltadevteam.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠For more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care⁠

Introduction: In this special episode of the Tick Boot Camp Podcast, recorded live at the International Lyme and Associated Diseases Society (ILADS) Conference, we welcome Wilberto Castillo, a representative of ArminLabs. ArminLabs, based in Augsburg, Germany, is a leading laboratory specializing in the diagnosis of tick-borne diseases, including Lyme disease. ArminLabs' Comprehensive Diagnostic Approach: Innovative Testing Methods: EliSpot Assay: Measures cellular immunity to detect active infections with an estimated sensitivity of 84% and specificity of 94%. iSpot Assay: Assesses the immune system's response to infections for deeper insights into immune activity. Wide Range of Pathogen Detection: Tests for Borrelia burgdorferi, the bacteria responsible for Lyme disease, as well as Bartonella, Babesia, Ehrlichia, and various viruses. Offers T-cell and NK-cell testing to assess immune system suppression and infection activity. Patient-Centric Services: Remote Testing Options: Provides an at-home blood collection kit to make testing more accessible. Personalized Test Recommendations: Uses patient questionnaires and analytical algorithms to recommend the most relevant tests for each individual. Resources & Links: Follow the latest ILADS updates at ILADS.org Learn more about ArminLabs at ArminLabs.com Stay connected with Tick Boot Camp: Website | Instagram | Facebook | YouTube | TikTok | Twitter (X)

Thanks to our Partner, NAPA Autotech Matt Fanslow dives into listener-submitted questions, covering:Multimeter recommendations (why he prefers insulation testers/meggers over basic DMMs).Electrical diagnostic strategies (schematics, scan tools, and stress-testing circuits).The "Flat Rate Test Drive" (a drivability diagnostic trick for load/PID analysis).Gaming picks (Elden Ring, Assassin's Creed Shadows, and Days Gone Remaster).Scan tool advice for techs doing more drivability work.Timestamps:(00:00) – Intro (02:33) – Multimeter recommendations: Why Matt avoids basic DMMs and prefers:Fluke 1587 or Pico TA467 (insulation testers for EVs/future-proofing).Used Vantage/Vantage Pro (graphing + scope functions).Curien (Bluetooth-enabled multimeter).(11:44) – Electrical diagnostic process:Start with a wiring schematic.Use a scan tool to check module inputs/commands.Stress-test circuits (e.g., load with a headlight for power/ground checks).Leverage relays for centralized testing (control/output sides).(22:48) – Shoutout to trainer Richard Velko.(23:17) – "Flat Rate Test Drive" explained:Monitor PIDs (load, MAF, MAP, O2 sensors) during WOT pulls to isolate drivability issues (fuel vs. restriction).(34:42) – Gaming corner: Elden Ring, Assassin's Creed Shadows, and Days Gone Remaster.(38:53) – Scan tool recommendations for drivability:HP Tuners (budget-friendly, fast data logging).Used Snap-on Solus Edge/Ultra (enhanced OEM data).Shop responsibility (tools should be shop-provided!).Quotes"I don't buy just a pure multimeter anymore... Get an insulation tester. You'll need it for EVs/hybrids." – Matt"The ‘Flat Rate Test Drive' stresses the engine while watching PIDs to split the problem in half." – Matt"For drivability, HP Tuners is my top pick—great data logging without breaking the bank." – MattTools & Resources Mentioned:Multimeters: Fluke 1587, Pico TA467, Vantage Pro, Curien.Diagnostic Tactics: Wiring diagrams, scan tool bi-directionals, current ramping.Games: Elden Ring, Assassin's Creed Shadows, Days Gone Remaster.Scan Tools: HP Tuners, Snap-on Solus Edge, TopDon XTool.Final Thoughts:Matt's takeaway? Invest in versatile tools (like megohmmeters) and lean on schematics/scan tools to avoid diagnostic rabbit holes.Thanks to our Partner, NAPA Autotech NAPA Autotech's team of ASE Master Certified Instructors are conducting over 1,200 classes covering 28 automotive topics. To see a selection, go to napaautotech.com for more details.Contact InformationEmail Matt: mattfanslowpodcast@gmail.comDiagnosing the Aftermarket A - Z YouTube Channel...

Lauren Rosenberg, a highly experienced Physician Associate, has dedicated nearly two decades to Internal Medicine and Health Optimization. Driven by a passion for preventative care, Lauren founded Vent Health to shift the focus from disease treatment to prevention. She specializes in a personalized approach that blends genetics, epigenetics, biomarkers, and lifestyle factors to tailor health interventions that extend and optimize each patient's health span. Lauren's practice includes prescribing peptides (GLP, CLP/GIP) for weight loss, insulin resistance, pre-diabetes, etc.  This episode concentrates on all the questions about GLP's, the prescription based Ozempic and others, as well as the Compound Pharmacy GLP's that can often times be less expensive.  Heather and Lauren also cover the common side effects, and how to manage them. In this episode you will learn other health benefits of these peptides, and who can benefit from them as well as practical tips for getting started on GLP-1 Therapy. Lauren is a frequent speaker at the Age Management Medicine Group (AMMG) and the American Academy of Anti-Aging Medicine (A4M) conferences.  Lauren's practice includes Cardiology prevention: Diagnostics and AI analysis to detect dangerous plaque and calcium; advanced lipid testing and cardiovascular genetics Longevity biomarkers: DNA methylation for biological age, VO2 max testing, Telomere health; Therapeutic plasma exchange Cancer prevention: methylated DNA screens, preventative MRIs, tumor marker testing. We will have Lauren back to discuss all these other longevity and optimum health subjects. This episode concentrates on the information pertaining to Peptides, GLP's etc as they are so popular right now. If you want to contact Lauren for more info, you can reach her via her site: https://myventhealth.com and go to the contact page. Or email: vent@myventhealth.com Social Media:  IG: https://www.instagram.com/iamheathert/            You Tube: https://youtube.com/@iamheathert?si=ZvI9l0bhLfTR-qdo Learn more about your ad choices. Visit megaphone.fm/adchoices

Exciting breakthroughs in preventive dentistry are happening right now, and you won't want to miss them! Join David and Pam as they sit down with Dr. Brian Novy to explore 10 innovations that are transforming patient care. From salivary diagnostics and CBD to taste-modifying technology and even the coziest scrubs, this episode is packed with insights that could elevate your practice and knowledge. Tune in for a fun and informative conversation that will keep you ahead of the curve!

Episode #168 with Dr Allan Pamba, Executive Vice President at Roche Diagnostics. Dr Allan Pamba is a global health leader and seasoned executive at the forefront of transforming healthcare systems through innovation, access, and sustainability. As Executive Vice President at Roche Diagnostics, the world's largest biotech company and a global pioneer in personalised healthcare, he brings decades of experience bridging the worlds of science, policy, and development to improve lives across Africa and beyond.In this episode, we dive into the urgent call for Africa to rethink its healthcare financing strategy, particularly around diagnostics amid shifting global policies and the threat of reduced foreign aid. With just five years left to meet the Abuja Declaration's 15% health budget commitment, Dr Pamba offers sharp insight into what it will take for African nations to move from dependency to self-reliance.What We Discuss With Dr AllanWhy do diagnostics, despite influencing 70% of clinical decisions, receive only 2% of healthcare funding in Africa?The potential impact of U.S. foreign policy shifts, including a possible return of the Global Gag Rule.How Africa can leverage economies of scale, pooled procurement, and regional collaboration to lower the cost of diagnostics.Ways African governments can create more attractive environments for private sector investment in diagnostics and healthcare infrastructure.Innovative financing models, public-private partnerships, and redefining government's role in health delivery.Did you miss my previous episode where I discuss Why the West Isn't Always Best: How Afro-Optimism Can Redefine African Success? Make sure to check it out!Like this show? Please leave us a review here -- even one sentence helps!Connect with Terser:LinkedIn - Terser AdamuInstagram - unlockingafricaTwitter (X) - @TerserAdamuConnect with Dr. Allan:LinkedIn - Dr Allan PambaTwitter (X) - @RocheDo you want to do business in Africa? Explore the vast business opportunities in African markets and increase your success with ETK Group. Connect with us at www.etkgroup.co.uk or reach out via email at info@etkgroup.co.ukSubscribe to our newsletter for exclusive content, behind-the-scenes insights, and bonus material - Unlocking Africa Newsletter

Join us for a special LIVE episode from the International Lyme and Associated Diseases Society (ILADS) Conference with Dr. Alexandr Zaitsev, the founder of Universal Diagnostic Laboratories. Dr. Zaitsev shares groundbreaking insights into advanced diagnostic testing for Lyme disease and other tick-borne illnesses. Comprehensive Tick-Borne Disease Testing Universal Diagnostic Laboratories has developed Tick Plex Plus, a panel test capable of detecting 12 different microorganisms, including Borrelia, Babesia, Bartonella, and more. The test leverages ELISA technology to provide a comprehensive assessment of a patient's tick-borne disease status. Addressing the Shift to Polymicrobial Infections Dr. Zaitsev discusses the increasing prevalence of poly-microbial infections, where patients present with multiple tick-borne pathogens. He attributes this shift to advancements in diagnostic technology, enabling detection of a broader range of microorganisms. Monitoring Treatment Progress Universal Diagnostic Laboratories offers a Long COVID test, which measures cytokine levels to track the body's inflammatory response and monitor treatment progress. Dr. Zaitsev recommends taking a baseline cytokine test and repeating it during or after treatment to assess improvements. Insurance Coverage and Accessibility Universal Diagnostic Laboratories collaborates with insurance providers, including Medicare, to make their tests affordable and accessible. The company strives to minimize out-of-pocket expenses while maintaining high-quality diagnostic solutions. Resources & Links Follow the latest ILADS updates: ILADS.org Learn more about Dr. Alexandr Zaitsev and Universal Diagnostic Laboratories: Universal Diagnostics Stay connected with Tick Boot Camp: Website | Instagram | Facebook | YouTube | TikTok | Twitter (X)

In this episode of the HVAC Know It All Podcast, host Gary McCreadie continues his conversation with Tim De Stasio, the owner and president of Comfort Science Solutions. In Part 2, he takes a closer look at the issues in HVAC caused by profit-focused decisions instead of customer care. He also discusses how company culture and investor pressure can affect service quality and ethical standards in the industry. Tim explains here in the part how some technicians are pressured to sell rather than fix real customer problems. He points out how this approach harms both the industry and customers in the long run. Tim emphasizes the need to focus on quality service instead of quick profits to create a more honest and sustainable business. Tim highlights the need to move away from profit-driven sales tactics in HVAC. He advocates for a culture that values technical skills and real problem-solving. He explores how ethical business practices can improve service quality and strengthen a company's reputation. Expect to Learn: How company culture influences HVAC technicians' approach to sales and service. The impact of venture capital on ethical practices within HVAC companies. Strategies for HVAC companies to adopt more ethical sales practices. The role of technician training in promoting problem-solving over sales-first approaches. How the industry can shift towards more sustainable and customer-focused practices. Episode Highlights: [00:33] – Introduction to the Second Part of the Episode with Tim De Stasio [02:19] – Transitioning from Comfort Advisors to Sales Technicians [05:24] – Analysis of venture capital's role in shaping company culture and ethical dilemmas [11:46] – Exploring the balance between making profits and providing ethical HVAC services [18:00] – Tim's take on the real-world impacts of prioritizing sales over service [21:22] – Promoting Ethical Training and Diagnostics in HVAC This Episode is Kindly Sponsored by: Master: https://www.master.ca/ Cintas: https://www.cintas.com/ Supply House: https://www.supplyhouse.com/ Cool Air Products: https://www.coolairproducts.net/ Lambert Insurance Services: https://www.lambert-ins.com/ Follow the Guest Tim De Stasio on: LinkedIn: https://www.linkedin.com/in/tim-de-stasio-0618824a/ Facebook: https://www.facebook.com/timothy.destasio Instagram: https://www.instagram.com/timdestasiohvac/ YouTube: https://www.youtube.com/@timdestasiohvac Comfort Science LP: https://www.instagram.com/comfortsciencehvac/ Follow the Host: LinkedIn: https://www.linkedin.com/in/gary-mccreadie-38217a77/ Website: https://www.hvacknowitall.com Facebook: https://www.facebook.com/people/HVAC-Know-It-All-2/61569643061429/ Instagram: https://www.instagram.com/hvacknowitall1/

In This Episode: Nicole Bell, CEO of Galaxy Diagnostics, shares her journey from personal experience with Lyme disease in her family to leading innovation in diagnostics. The connection between tick-borne pathogens and chronic diseases like early-onset Alzheimer's. Why traditional Lyme disease tests often fail and the need for direct detection methods. The latest advancements in testing for Borrelia, Bartonella, Babesia, and other stealth pathogens. The impact of Nicole's "State of Lyme Disease Research" report on the Lyme community. What patients and healthcare providers need to know about cutting-edge diagnostic tools. Why This Matters: An increasing number of studies link flea- and tick-borne pathogens to chronic illnesses affecting the joints, heart, and central nervous system. These infections mimic conditions like lupus and fibromyalgia, making them hard to diagnose without advanced testing. Galaxy Diagnostics offers specialized tests to detect Lyme Borrelia, Bartonella, Babesia, Anaplasma, Ehrlichia, and Rickettsia species—providing a much-needed solution for patients seeking accurate diagnoses. Resources & Links:

Is America REALLY less healthy than it used to be? Or is that just a myth?  Lately, the Make America Healthy Again (MAHA) movement has been romanticizing the past—but was it really a "healthier" time?